NewSpring Capital and Kineticos Life Sciences Lead $22 Million Investment in Cell Therapy CDMO, Kincell Bio; Appoints Industry Veteran Pete Buzy to Board of Directors
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Kincell Bio announced the completion of a $22 million round, led by a new investor, NewSpring Capital through its dedicated healthcare strategy, NewSpring Healthcare, which invests in innovative companies in the…